Jazz Pharmaceuticals
JAZZ
#1651
Rank
โ‚น1.238 T
Marketcap
โ‚น19,741
Share price
2.63%
Change (1 day)
97.60%
Change (1 year)

Earnings for Jazz Pharmaceuticals (JAZZ)

Earnings in 2025 (TTM): -โ‚น52.92 Billion

According to Jazz Pharmaceuticals's latest financial reports the company's current earnings are โ‚น4.26 Billion. a decrease over its 2024 earnings that were of โ‚น44.62 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Jazz Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 -โ‚น59.58 Billion-233.49%
2024 โ‚น44.62 B57.87%
2023 โ‚น28.26 B-179.92%
2022 -โ‚น35.37 Billion230.37%
2021 -โ‚น10.71 Billion-141.02%
2020 โ‚น26.10 B-39.45%
2019 โ‚น43.10 B-14.2%
2018 โ‚น50.23 B20.03%
2017 โ‚น41.85 B-17.15%
2016 โ‚น50.51 B22.14%
2015 โ‚น41.36 B187.64%
2014 โ‚น14.37 B-50.79%
2013 โ‚น29.21 B73.63%
2012 โ‚น16.82 B41.69%
2011 โ‚น11.87 B116.61%
2010 โ‚น5.48 B262.77%
2009 โ‚น1.51 B-111.33%
2008 -โ‚น13.35 Billion1.31%
2007 -โ‚น13.17 Billion77.8%
2006 -โ‚น7.41 Billion36.59%
2005 -โ‚น5.43 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
โ‚น1.551 T-2,704.41%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AmerisourceBergen
ABC
โ‚น198.93 B-433.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Endo International
ENDPQ
-โ‚น226.95 Billion 280.96%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Teva Pharmaceutical Industries
TEVA
โ‚น204.18 B-442.75%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel